Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Working Capital Changes: 2011-2024

Historic Other Working Capital Changes for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $2.7 million.

  • Adma Biologics' Other Working Capital Changes fell 127.78% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$538,000, marking a year-over-year decrease of 112.12%. This contributed to the annual value of $2.7 million for FY2024, which is 1027.62% up from last year.
  • Adma Biologics' Other Working Capital Changes amounted to $2.7 million in FY2024, which was up 1,027.62% from $239,000 recorded in FY2023.
  • Adma Biologics' 5-year Other Working Capital Changes high stood at $2.7 million for FY2024, and its period low was $239,000 during FY2023.
  • For the 3-year period, Adma Biologics' Other Working Capital Changes averaged around $1.2 million, with its median value being $756,000 (2022).
  • Per our database at Business Quant, Adma Biologics' Other Working Capital Changes slumped by 68.39% in 2023 and then soared by 1,027.62% in 2024.
  • Adma Biologics' Other Working Capital Changes (Yearly) stood at $512,873 in 2020, then soared by 152.11% to $1.3 million in 2021, then crashed by 41.53% to $756,000 in 2022, then plummeted by 68.39% to $239,000 in 2023, then soared by 1,027.62% to $2.7 million in 2024.